Successful treatment of primary chronic osteomyelitis in SAPHO syndrome with bisphosphonates;Bisphosphonate als erfolgreiches behandlungsprinzip der primär chronischen osteomyelitis beim SAPHO-syndrom

JDDG - Journal of the German Society of Dermatology

Volumn 6, Issue 8, 2008, Pages 657-660

  Just, Alexander ^a   Adams, Sabine ^a   Brinkmeier, Thomas ^a   Barsegian, Vahé ^a   Lorenzen, Johannes ^a   Schilling, Fritz ^b   Frosch, Peter ^a  

^a KLINIKUM DORTMUND   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Acne; CRMO; Pustular psoriasis; Zoledronic acid

Indexed keywords

ETRETIN; IBUPROFEN; PREDNISOLONE; ZOLEDRONIC ACID;

ADULT; ARTHRALGIA; ARTICLE; BONE SCINTISCANNING; CASE REPORT; CELL ACTIVITY; CHRONIC OSTEOMYELITIS; DIAGNOSTIC PROCEDURE; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; OSTEOCHONDRITIS; OSTEOCLAST; PAIN ASSESSMENT; PUSTULOSIS PALMOPLANTARIS; PUVA; SAPHO SYNDROME; SINGLE DRUG DOSE; STERNOCLAVICULAR JOINT; STERNUM;

ACQUIRED HYPEROSTOSIS SYNDROME; BONE DENSITY CONSERVATION AGENTS; CHRONIC DISEASE; DIPHOSPHONATES; FEMALE; HUMANS; MIDDLE AGED; OSTEOMYELITIS; TREATMENT OUTCOME;

EID: 49149090220     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2008.06588.x     Document Type: Article

References (10)

1. Chamot AM, Benhamou CL, Kahn MF, Beraneck L, Kaplan G, Prost A. Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey. 85 cases. Rev Rhum Mal Osteoartic 1987 54 (3 187 196.
2. Schilling F. SAPHO-syndrom. Orphanet Enzyklopädie 2004/6 : http://www.orpha.net/data/patho/DE/de-sapho.pdf
3. Kopterides P, Pikazis D, Koufos C. Successful treatment of SAPHO syndrome with zoledronic acid. Arthritis Rheum 2004 50 (9 2970 2973.
4. Kerrison C, Davidson JE, Cleary AG, Beresford MW. Pamidronate in the treatment of childhood SAPHO syndrome. Rheumatology (Oxford) 2004 43 (10 1246 1251.
5. Amital H, Applbaum YH, Aamar S, Daniel N, Rubinow A. SAPHO syndrome treated with pamidronate: an open-label study of 10 patients. Rheumatology (Oxford) 2004 43 (5 658 661.
6. Hayem G, Bouchaud-Chabot A, Benali K, Roux S, Palazzo E, Silbermann-Hoffman O, Kahn MF, Meyer O. SAPHO syndrome: A long-term follow-up study of 120 cases. Semin Arthr Rheumat 1999 29 : 159 171.
7. Olivieri I, Padula A, Palazzi C. Pharmacological management of SAPHO syndrome. Expert Opin Investig Drugs 2006 15 (10 1229 1233.
8. Iqbal M, Kolodney MS. Acne fulminans with synovitis-acne-pustulosis- hyperostosis-osteitis (SAPHO) syndrome treated with infliximab. J Am Acad Dermatol 2005 52 (5 Suppl 1 118 120.
9. Schilling F, Wagner AD. Azithromycin: an antiinflammatory effect in chronic recurrent multifocal osteomyelitis? A preliminary report. Z Rheumatol 2000 59 (5 352 353.
10. Schilling F. Das SAPHO-Syndrom - Nosologische Heterogenität und diagnostische Differenzierung - mit rheumatologischer Osteologie hyperostotischer Spondarthritiden. Akt Rheumatol 1998 23 (Suppl 1 1 64.